ENTRY       D04539                      Drug
NAME        Insulin detemir (USAN/INN);
            Insulin detemir (genetical recombination) (JAN);
            Levemir (TN)
PRODUCT     LEVEMIR (A-S Medication Solutions)
            LEVEMIR (A-S Medication Solutions)
            LEVEMIR (A-S Medication Solutions)
            LEVEMIR (Novo Nordisk)
FORMULA     C267H402N64O76S6
EXACT_MASS  5912.7883
MOL_WEIGHT  5916.822
SEQUENCE    (A chain) Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr
            Gln Leu Glu Asn Tyr Cys Asn
            (B chain) Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala
            Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro
            Lys-C14H27O
            (Disulfide bridge: A6-A11, A7-B7, A20-B19)
  TYPE      Peptide
CLASS       Antidiabetic agent
             DG01636  Insulin preparation
              DG01797  Insulin analog, long-acting
            Metabolizing enzyme inducer
             DG01637  CYP1A2 inducer
REMARK      Therapeutic category: 2492
            ATC code: A10AE05
            Product: D04539<JP/US>
EFFICACY    Antidiabetic, Insulin receptor agonist
  DISEASE   Diabetes mellitus [DS:H00408 H00409]
COMMENT     Insulin analog
TARGET      INSR (CD220) [HSA:3643] [KO:K04527]
  PATHWAY   hsa04910(3643)  Insulin signaling pathway
            hsa04930(3643)  Type II diabetes mellitus
INTERACTION CYP induction: CYP1A2 [HSA:1544]
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10A INSULINS AND ANALOGUES
                A10AE Insulins and analogues for injection, long-acting
                 A10AE05 Insulin detemir
                  D04539  Insulin detemir (USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Insulins
               Insulin, Long-acting
                Insulin Detemir
                 D04539  Insulin detemir (USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2492  Pancreatic hormones
                 D04539  Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG01636  Insulin preparation
               DG01797  Insulin analog, long-acting
                D04539  Insulin detemir
             Metabolizing enzyme inducer
              DG01637  CYP1A2 inducer
               D04539  Insulin detemir
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01636  Insulin preparation
               D04539  Insulin detemir
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               INSR family
                INSR (CD220)
                 D04539  Insulin detemir (USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04539
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04539
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04539
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04539
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D04539
DBLINKS     CAS: 169148-63-4
            PubChem: 17398128
            NIKKAJI: J2.337.674A
///
